ReviewFrontiers in neurology2026
Imaging studies for predicting hematoma expansion: from traditional imaging signs to artificial intelligence-based multimodal fusion.
Review in Frontiers in neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hematoma expansion (HE) is a critical and modifiable event following acute intracerebral hemorrhage (ICH). Predicting HE accurately can inform individualized treatment and improve patient outcomes. This review systematically outlines the evolution of imaging-based HE prediction. We first define the core concepts of traditional HE, revised HE (rHE), and ultra-early hematoma growth (uHG). We then summarize predictive studies that employ traditional imaging markers, such as the computed tomography angiography (CTA) spot sign, non-contrast CT (NCCT) signs, and combined clinical-imaging scoring systems. Subsequent sections focus on AI-driven methodologies, encompassing radiomics, deep learning, and multi-task learning. The discussion extends to precision prediction through multimodal data fusion and subgroup analyses based on hemorrhage location and onset time. Finally, we address persistent challenges, including model interpretability, generalizability, and translational gaps, and suggest future directions involving federated learning, explainable AI, dynamic prediction, and closed-loop decision systems. This review offers a structured framework to guide both clinical practice and future research.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.